KORU MEDICAL SYSTEMS, INC.: gross property, plant and equipment

What this measure means

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Exact concept: us-gaap:PropertyPlantAndEquipmentGross. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2012-02-29 to 2025-12-31. The SEC response was captured on 2026-09-19.

Selected filing history

Related financial histories

• KORU MEDICAL SYSTEMS, INC.: total assets
• KORU MEDICAL SYSTEMS, INC.: total liabilities
• KORU MEDICAL SYSTEMS, INC.: stockholders equity
• KORU MEDICAL SYSTEMS, INC.: cash and cash equivalents
• KORU MEDICAL SYSTEMS, INC.: net income or loss
• KORU MEDICAL SYSTEMS, INC.: operating cash flow
• KORU MEDICAL SYSTEMS, INC.: capital expenditure payments
• KORU MEDICAL SYSTEMS, INC.: revenue
• KORU MEDICAL SYSTEMS, INC.: financing cash flow
• KORU MEDICAL SYSTEMS, INC.: investing cash flow
• KORU MEDICAL SYSTEMS, INC.: retained earnings or deficit
• KORU MEDICAL SYSTEMS, INC.: basic weighted-average shares
• KORU MEDICAL SYSTEMS, INC.: diluted weighted-average shares
• KORU MEDICAL SYSTEMS, INC.: basic earnings per share
• KORU MEDICAL SYSTEMS, INC.: diluted earnings per share
• KORU MEDICAL SYSTEMS, INC.: income tax expense or benefit
• KORU MEDICAL SYSTEMS, INC.: net property, plant and equipment
• KORU MEDICAL SYSTEMS, INC.: share-based compensation expense
• KORU MEDICAL SYSTEMS, INC.: operating income or loss
• KORU MEDICAL SYSTEMS, INC.: current assets
• KORU MEDICAL SYSTEMS, INC.: interest expense
• KORU MEDICAL SYSTEMS, INC.: current liabilities
• KORU MEDICAL SYSTEMS, INC.: current accounts payable
• KORU MEDICAL SYSTEMS, INC.: net finite-lived intangible assets
• KORU MEDICAL SYSTEMS, INC.: net current accounts receivable
• KORU MEDICAL SYSTEMS, INC.: operating expenses
• KORU MEDICAL SYSTEMS, INC.: net inventory
• KORU MEDICAL SYSTEMS, INC.: gross profit
• KORU MEDICAL SYSTEMS, INC.: selling, general and administrative expense
• KORU MEDICAL SYSTEMS, INC.: research and development expense
• KORU MEDICAL SYSTEMS, INC.: common shares outstanding
• KORU MEDICAL SYSTEMS, INC.: operating lease right-of-use asset
• KORU MEDICAL SYSTEMS, INC.: operating lease liability
• KORU MEDICAL SYSTEMS, INC.: accumulated depreciation on property, plant and equipment
• KORU MEDICAL SYSTEMS, INC.: net intangible assets excluding goodwill
• KORU MEDICAL SYSTEMS, INC.: other noncurrent assets
• KORU MEDICAL SYSTEMS, INC.: accrued current liabilities
• KORU MEDICAL SYSTEMS, INC.: net deferred tax assets
• KORU MEDICAL SYSTEMS, INC.: pre-tax income or loss from continuing operations
• KORU MEDICAL SYSTEMS, INC.: depreciation expense
• KORU MEDICAL SYSTEMS, INC.: depreciation, depletion and amortization
• KORU MEDICAL SYSTEMS, INC.: other nonoperating income or expense
• KORU MEDICAL SYSTEMS, INC.: nonoperating income or expense
• KORU MEDICAL SYSTEMS, INC.: deferred income tax expense or benefit
• KORU MEDICAL SYSTEMS, INC.: interest paid, net
• KORU MEDICAL SYSTEMS, INC.: income taxes paid, net
• KORU MEDICAL SYSTEMS, INC.: proceeds from issuing common stock
• KORU MEDICAL SYSTEMS, INC.: operating lease payments
• KORU MEDICAL SYSTEMS, INC.: change in accounts receivable
• KORU MEDICAL SYSTEMS, INC.: change in inventories
• KORU MEDICAL SYSTEMS, INC.: change in accounts payable

Inspect the source

Entity

KORU MEDICAL SYSTEMS, INC. / CIK 0000704440

Captured

2026-09-19T14:58:00.731Z

SEC response SHA-256

b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))